通讯作者: 杨冯静, missfrank@126.com

DOI：10.12201/bmr.202510.00061

Analysis of Staged Treatment of Chronic Heart Failure Using the Warming and Suppressing Method

• 摘要：慢性心力衰竭(CHF)是心血管疾病发展的终末阶段,现代医学虽有多靶点药物治疗,但仍面临耐药性与病情反复的挑战。本文基于武汉市中医医院杨冯静教授“阳主阴从、阳密乃固”的理论观点,提出CHF的核心病机为阳气亏虚、阴邪肆虐、虚阳浮越,强调治疗需以温潜法为枢纽,通过温阳与潜镇相结合,实现“阴平阳密”。根据阳气耗散的程度分阶段论述温潜法的辨证应用：代偿期以轻剂温潜防微杜渐；失代偿期重在峻温重潜、涤荡浊邪；终末期则亟需回阳救逆、固摄真阳。附验案一则,临床效果显著,体现了中西医结合在CHF治疗中的显著优势,为临床提供了一种行之有效的诊疗思路。

  关键词： 慢性心力衰竭; 温潜法; 分期论治; 名医经验

   

  Abstract: Chronic heart failure (CHF) represents the end-stage progression of cardiovascular diseases. Although modern medicine offers multi-target pharmacological interventions, challenges such as drug resistance and disease recurrence persist. Based on Professor Yang Fengjing’s theoretical perspective ofS“Yang governing Yin, with Yang consolidation ensuring stability”S at Wuhan Hospital of Traditional Chinese Medicine, this article proposes that the core pathogenesis of CHF involvesSdeficiency of Yang Qi,Sproliferation of pathogenic Yin, andSfloating of deficient Yang. It emphasizes the application of theSwarming and suppressing methodS as a pivotal strategy, combiningSwarming YangSandSsuppressing hyperactivitySto achieveS“Yin Ping Yang Mi”.The differential application of the warming and suppressing method is discussed according to the stage of Yang Qi consumption:During theScompensated stage, mild warming and suppressing are used to prevent progression;In theSdecompensated stage, strong warming and heavy suppressing are emphasized to eliminate turbid pathogens;At theSend stage, urgent revival of Yang and consolidation of genuine Yang are critical.A case example is included, demonstrating significant clinical outcomes and highlighting the advantages of integrating traditional Chinese and Western medicine in treating CHF. This approach provides an effective diagnostic and therapeutic framework for clinical practice.

  Key words: SChronic Heart Failure; Warming And Suppressing Method; Treatment By Stage; Proven Experience Of Distinguished Physicians

  提交时间：2025-10-31

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 郑杰媚, 邱小芩, 韦吉思, 丘欣雨, 刘娜, 陈思帆. 慢性心力衰竭患者症状群的范围综述. 2025. doi: 10.12201/bmr.202501.00046

  周航宇, 李杰. 射血分数保留的心力衰竭合并慢性肾脏疾病的研究进展. 2025. doi: 10.12201/bmr.202504.00077

  薛琴丹. 健康素养在慢性心力衰竭患者症状负担与疾病不确定感间的调节效应分析. 2024. doi: 10.12201/bmr.202407.00062

  蔡欣欣, 吴夏阳. SGLT2i治疗心力衰竭的作用机制及研究进展. 2025. doi: 10.12201/bmr.202507.00052

  蔡杰, 韩陈媛. 某三级医院慢性射血分数降低心力衰竭住院患者指南导向药物应用分析与评价. 2025. doi: 10.12201/bmr.202507.00076

  赵家云. 基于循证的营养护理对重症心力衰竭患者疾病转归的影响. 2025. doi: 10.12201/bmr.202503.00018

  王敏旭, 帕尔哈提·吐尔逊. 炎症与铁缺乏在心力衰竭患者预后中的预测作用. 2025. doi: 10.12201/bmr.202507.00038

  苏照海, 曹竣, 杨荣源, 刘擎, 刘青艳. 哮喘相关性肺炎与心力衰竭因果关系的双向两样本孟德尔随机化研究. 2025. doi: 10.12201/bmr.202509.00016

  马家慧, 王忠. 心力衰竭患者血浆C1q/肿瘤坏死因子相关蛋白6、系统性炎症反应指数水平及临床意义. 2025. doi: 10.12201/bmr.202501.00060

  熊双琳, 徐萍. 从心脾论治儿童期特应性皮炎经验探析. 2024. doi: 10.12201/bmr.202412.00043

• 序号	提交日期	编号	操作
  1	2025-10-26	10.12201/bmr.202510.00061V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论